INSIGHTS ON CLINICAL TRIAL DESIGN
-
5 Strategies For Designing Successful Complex Rare Disease Trials
Rare disease trials demand inventive design. Uncover creative strategies that help sponsors overcome tiny populations, complex endpoints, and operational hurdles to advance meaningful breakthroughs.
-
How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?
Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.
-
The Final DCT Guidance: I'm Not Mad At It
Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
Assessing Diversity In Early-Phase Clinical Trials In A Rapidly Changing Regulatory Environment
Learn more about structuring early-phase trials to address population variation and the contributing factors to safe drug administration, both of which are essential to a drug development plan.
-
Evidence Of An Industry's Readiness To Collaborate11/13/2024
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
-
Unveiling The Potential Of Psychedelic Therapies7/30/2024
Leading experts highlight the transformative potential of the rapidly evolving field of psychedelic therapies and underscore the importance of rigorous clinical trials and regulatory compliance.
-
Streamlining Pediatric Clinical Trials With Vestigo®5/8/2026
Utilizing a centralized, automated platform can eliminate the friction of manual accountability logs, ensuring audit readiness while providing real-time visibility into financial reporting.
-
Cell And Gene Therapy Field Quiet In Q28/15/2024
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Outsourcing Patient Recruitment: What You Need To Know8/18/2025
Sponsors and CROs are increasingly outsourcing patient recruitment to specialized vendors to address the ongoing challenge of meeting initial recruitment targets on time.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Obtain smarter, faster, and more resilient clinical trials that reduce cost, improve outcomes, and bring life-changing therapies to patients sooner with integrated, user-friendly technology.
-
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.
-
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.